“The aim at the improvement of security and durability of anti-CD19 CAR-T cell” of Qilu Cell Therapy Technology Co., Ltd has acquired project approval of “Shandong province’s key research and plan (key technology)” of Science and Technology Department of Shandong Province recently and it gains 1 million science and technology funding totally.

“Shandong province’s key research and plan (key technology)” is a platform where the government of Shandong Province accelerates the implementation of strategy of innovation-driven development, promotes industrial independent innovation ability, foster innovative industrial clusters, speeds up to promote supply-side reform and improves the province’s development of economic restructuring and upgrading. Qilu Cell Therapy Technology Co., Ltd takes the promotion of industrial technology upgrading and structural adjustment and the solution of important social technological problem as the major direction. In addition, this company supplies technological support for industrial structure adjustment, the fostering of emerging industry, social sustainable development and the improvement of citizens’ living standard through the breakthrough of key skills, the innovation of introduced technology and the application and industrialization of high-tech.

This project gathers advanced science and technology and sets up a high-level and high-quality technological research and development team, which supply powerful guarantee for the sustainable improvement and long-term development of core technology.